This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (The Hill) — Pfizer announced on Thursday it ...
Pfizer on Tuesday said prescriptions for its oral antiviral to treat Covid-19 have increased nearly tenfold in the U.S. since late February, as more pharmacies and other locations receive supply. CEO ...
Hosted on MSN
Pfizer battles another Paxlovid lawsuit from Enanta
If you don’t succeed at first, try again – in separate regions. That’s the motto Enanta Pharmaceuticals is following, at least, after disclosing it has sued Pfizer in Europe over a patent infringement ...
Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental COVID-19 pill. The agreement with the Medicines Patent Pool, a United Nations-backed public ...
A company spokesperson on Wednesday confirmed the price, which was first reported by The Wall Street Journal. That list price, which is before rebates and other discounts to insurers and pharmacy ...
Hosted on MSN
Pfizer’s Paxlovid Study: A Potential Game-Changer for COVID-19 Treatment in Korean Long-term Care Hospitals
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results